Envista Holdings (NVST) Depreciation and Depletion (2018 - 2026)
Envista Holdings' (NVST) quarterly Depreciation and Depletion came in at $10.4 million in Q2 2026, up 14.29% year-on-year from $9.1 million in Q2 2025, and up 2.97% quarter-over-quarter from $10.1 million in Q4 2025.
Envista Holdings (NVST) Depreciation and Depletion (2018 - 2026) Analysis & Trends
Envista Holdings' Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $10.4 million for Q2 2026.
- On a quarterly basis, Depreciation and Depletion rose 14.29% year-over-year to $10.4 million in Q2 2026; TTM through Apr 2026 was $41.4 million, a 2.48% increase from a year earlier, with the FY2025 full-year figure at $40.1 million, down 1.72% from the prior year.
- Depreciation and Depletion rose to $10.4 million in Q2 2026 per NVST's latest filing, from $10.1 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $11.6 million in Q2 2024 and bottomed at $7.8 million in Q2 2022.
- The 5-year median for Depreciation and Depletion is $9.2 million (2023), against an average of $9.4 million.
- Across the five-year window, Depreciation and Depletion plunged 30.7% in 2022 and advanced 23.4% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $7.9 million in 2022, then climbed by 16.46% to $9.2 million in 2023, then changed by 0.0% to $9.2 million in 2024, then increased by 9.78% to $10.1 million in 2025, then rose by 2.97% to $10.4 million in 2026.
- Per Business Quant, the three latest NVST Depreciation and Depletion figures stand at $10.4 million (Q2 2026), $10.1 million (Q4 2025), and $10.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 47.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 38.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 15.60 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | 10.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 10.40 Mn |
| Apr 3, 2026 | 10.40 Mn |
| Dec 31, 2025 | 10.10 Mn |
| Dec 31, 2025 | 10.10 Mn |
| Sep 26, 2025 | 10.10 Mn |
| Sep 26, 2025 | 10.10 Mn |
| Jun 27, 2025 | 10.80 Mn |
| Jun 27, 2025 | 10.80 Mn |
| Mar 28, 2025 | 9.10 Mn |
| Mar 28, 2025 | 9.10 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Sep 27, 2024 | 10.50 Mn |
| Sep 27, 2024 | 10.50 Mn |
| Jun 28, 2024 | 11.60 Mn |
| Jun 28, 2024 | 11.60 Mn |
| Mar 29, 2024 | 9.50 Mn |
| Mar 29, 2024 | 9.50 Mn |
| Dec 31, 2023 | 9.20 Mn |
| Dec 31, 2023 | 9.20 Mn |